Cargando…
High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea: the adjusted analytical change limit (adjACL) for small variations at low concentrations
Interpreting change in cardiac troponin after CPAP in OSA is challenging, especially since the lower the troponin concentration, the higher the analytical imprecision. In such cases, the adjusted analytical change limit (adjACL) should be used. https://bit.ly/3eaHcuq
Autor principal: | Monneret, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850686/ https://www.ncbi.nlm.nih.gov/pubmed/35058243 http://dx.doi.org/10.1183/13993003.03022-2021 |
Ejemplares similares
-
Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea
por: Justeau, Grégoire, et al.
Publicado: (2022) -
Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment
por: Palm, Andreas, et al.
Publicado: (2022) -
Impact of COVID-19 lockdown on adherence to continuous positive airway pressure by obstructive sleep apnoea patients
por: Attias, David, et al.
Publicado: (2020) -
BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)
por: Gaisl, Thomas, et al.
Publicado: (2021) -
Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA)
por: Grote, Ludger, et al.
Publicado: (2020)